A role for caspase 2 and PIDD in the process of p53-mediated apoptosis

Nicole Baptiste-Okoh1, Anthony M Barsotti, Carol Prives

  • 1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.

Insights

DNA-damaging agents trigger apoptosis via p53, involving PIDD and caspase 2. This pathway is crucial for cytochrome c release and cell death, even with a defective p53 transactivation domain.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The tumor suppressor protein p53 plays a critical role in cellular responses to DNA damage.
  • p53's transactivation domain is essential for regulating target gene expression and mediating apoptosis.
  • Mutant p53 variants can retain or gain functions, impacting cancer progression and treatment response.

Purpose of the Study:

  • To investigate the role of a p53 mutant with an inactive transactivation domain (p53(Q22/S23)) in DNA damage-induced apoptosis.
  • To elucidate the specific molecular mechanisms and key mediators involved in p53-dependent apoptosis, particularly concerning caspase activation and target gene induction.
  • To determine whether p53's transcriptional activity is fully required for initiating apoptosis or for downstream events.

Main Methods:

  • Utilized human tumor-derived H1299 cells expressing inducible wild-type or mutant p53(Q22/S23).
  • Applied DNA-damaging agents to induce apoptosis.
  • Assessed apoptosis through cytochrome c release, nuclear fragmentation, and DNA content analysis.
  • Investigated caspase activation, specifically caspase 2.
  • Examined the expression of proapoptotic target genes like PIDD and AIP1.
  • Employed RNA interference (RNAi) to silence PIDD and assess its impact on apoptosis.

Main Results:

  • p53(Q22/S23) induced apoptosis, characterized by cytochrome c release, nuclear fragmentation, and sub-G1 DNA content, although at a slower rate than wild-type p53.
  • Key downstream effector caspases were not activated, but caspase 2 activation was essential for cytochrome c release and cell death.
  • Despite a defective transactivation domain, p53(Q22/S23) induced proapoptotic targets PIDD and AIP1 similarly to wild-type p53.
  • Silencing PIDD using RNAi suppressed apoptosis induced by both wild-type p53 and p53(Q22/S23).

Conclusions:

  • The initial phase of DNA damage-induced, p53-mediated apoptosis relies on a mechanism involving PIDD and caspase 2.
  • Caspase 2 activation is a critical early event required for cytochrome c release and subsequent cell death.
  • Full transcriptional regulatory functions of p53 may not be necessary for the initiation of apoptosis but rather for events occurring downstream of cytochrome c release.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...